These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 23257706

  • 1. Hepatocellular carcinoma and chemotherapy: the role of p53.
    Brito AF, Abrantes AM, Pinto-Costa C, Gomes AR, Mamede AC, Casalta-Lopes J, Gonçalves AC, Sarmento-Ribeiro AB, Tralhão JG, Botelho MF.
    Chemotherapy; 2012; 58(5):381-6. PubMed ID: 23257706
    [Abstract] [Full Text] [Related]

  • 2. A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells.
    Lo SJ, Fan LC, Tsai YF, Lin KY, Huang HL, Wang TH, Liu H, Chen TC, Huang SF, Chang CJ, Lin YJ, Yung BY, Hsieh SY.
    Hepatology; 2013 May; 57(5):1893-905. PubMed ID: 23258611
    [Abstract] [Full Text] [Related]

  • 3. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway.
    Jiao J, Hong S, Zhang J, Ma L, Sun Y, Zhang D, Shen B, Zhu C.
    Cancer Lett; 2012 Jul 01; 320(1):96-103. PubMed ID: 22313545
    [Abstract] [Full Text] [Related]

  • 4. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
    Zhang G, Zeng X, Zhang R, Liu J, Zhang W, Zhao Y, Zhang X, Wu Z, Tan Y, Wu Y, Du B.
    Phytomedicine; 2016 Nov 15; 23(12):1329-1336. PubMed ID: 27765352
    [Abstract] [Full Text] [Related]

  • 5. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells.
    Yang L, Wu D, Luo K, Wu S, Wu P.
    Cancer Lett; 2009 Apr 18; 276(2):180-8. PubMed ID: 19097688
    [Abstract] [Full Text] [Related]

  • 6. Pro-apoptotic and anticancer properties of Thapring - A Tibetan herbal formulation.
    Choedon T, Dolma D, Kumar V.
    J Ethnopharmacol; 2011 Sep 01; 137(1):320-6. PubMed ID: 21658439
    [Abstract] [Full Text] [Related]

  • 7. Regulation of p53-, Bcl-2- and caspase-dependent signaling pathway in xanthorrhizol-induced apoptosis of HepG2 hepatoma cells.
    Handayani T, Sakinah S, Nallappan M, Pihie AH.
    Anticancer Res; 2007 Sep 01; 27(2):965-71. PubMed ID: 17465228
    [Abstract] [Full Text] [Related]

  • 8. Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma.
    Miao J, Chen GG, Chun SY, Chak EC, Lai PB.
    Int J Oncol; 2004 Sep 01; 25(3):651-9. PubMed ID: 15289866
    [Abstract] [Full Text] [Related]

  • 9. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 01; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 10. Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells.
    Jiang MC, Luo SF, Li LT, Lin CC, Du SY, Lin CY, Hsu YW, Liao CF.
    J Exp Clin Cancer Res; 2007 Mar 01; 26(1):91-9. PubMed ID: 17550137
    [Abstract] [Full Text] [Related]

  • 11. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
    Xu SP, Sun GP, Shen YX, Peng WR, Wang H, Wei W.
    Acta Pharmacol Sin; 2007 Jun 01; 28(6):869-78. PubMed ID: 17506946
    [Abstract] [Full Text] [Related]

  • 12. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
    Leng AM, Liu T, Yang J, Cui JF, Li XH, Zhu YN, Xiong T, Zhang G, Chen Y.
    Cell Biol Int; 2012 Oct 01; 36(10):893-9. PubMed ID: 22694478
    [Abstract] [Full Text] [Related]

  • 13. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY, Kim GY, Kim ND, Jung JH, Kim SK, Kang HS, Choi YH.
    Oncol Rep; 2008 Feb 01; 19(2):517-26. PubMed ID: 18202802
    [Abstract] [Full Text] [Related]

  • 14. Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.
    Zhao J, Jin J, Zhang X, Shi M, Dai J, Wu M, Wang R, Guo Y.
    Cancer Gene Ther; 2006 Apr 01; 13(4):420-7. PubMed ID: 16211087
    [Abstract] [Full Text] [Related]

  • 15. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Dono K, Monden M.
    J Hepatol; 2007 Jan 01; 46(1):77-88. PubMed ID: 17045692
    [Abstract] [Full Text] [Related]

  • 16. New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin.
    Brito AF, Ribeiro M, Abrantes AM, Mamede AC, Laranjo M, Casalta-Lopes JE, Gonçalves AC, Sarmento-Ribeiro AB, Tralhão JG, Botelho MF.
    Nutr Cancer; 2016 Jan 01; 68(2):250-66. PubMed ID: 26943884
    [Abstract] [Full Text] [Related]

  • 17. Overexpressed nuclear BAG-1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin.
    Ni W, Chen B, Zhou G, Lu C, Xiao M, Guan C, Zhang Y, He S, Shen A, Ni R.
    J Cell Biochem; 2013 Sep 01; 114(9):2120-30. PubMed ID: 23553841
    [Abstract] [Full Text] [Related]

  • 18. Wild type p53 increased chemosensitivity of drug-resistant human hepatocellular carcinoma Bel7402/5-FU cells.
    Li YX, Lin ZB, Tan HR.
    Acta Pharmacol Sin; 2004 Jan 01; 25(1):76-82. PubMed ID: 14704126
    [Abstract] [Full Text] [Related]

  • 19. TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.
    Koehler BC, Urbanik T, Vick B, Boger RJ, Heeger S, Galle PR, Schuchmann M, Schulze-Bergkamen H.
    World J Gastroenterol; 2009 Dec 21; 15(47):5924-35. PubMed ID: 20014456
    [Abstract] [Full Text] [Related]

  • 20. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
    Liu H, Chen W, Liang C, Chen BW, Zhi X, Zhang S, Zheng X, Bai X, Liang T.
    Cancer Lett; 2015 Jun 01; 361(2):218-25. PubMed ID: 25749422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.